OCT 01, 2015 6:00 AM PDT

Emerging role of liquid biopsies and NGS for biomarker discovery

Speaker

Abstract

Precision medicine promises a more effective approach to disease treatment and management. It is based on analyzing mutations of disease samples to unlock mechanisms of disease development and progression, and resistance to effective therapies. Recent advances in NGS have made it the ideal approach for the comprehensive analysis of the mutational landscape of samples. Specifically, the ability to enrich certain genomic targets known, or suspected, to harbor driver mutations prior to NGS is allowing researchers to achieve very deep levels of sequencing coverage, levels that cannot be achieved by either WGA or WES, thereby increasing the sensitivity of NGS assays. The ability to enrich genomic targets has also facilitated the use of liquid biopsies for the discovery of mutations that contribute to drug resistance. Several challenges remain though, mainly the specificity and uniformity of target enrichment approaches, the amount of required DNA, and the turnaround time needed to go from sample to insight. Attend this seminar to learn what solutions QIAGEN scientists have developed to overcome these challenges and how these solutions can be used to analyze mutations in a wide range of samples such as FFPE, cfDNA, and CTCs, thereby enabling researchers to use solid and liquid biopsies for disease management and, ultimately, precision medicine.


Show Resources
You May Also Like
SEP 14, 2021 7:00 AM PDT
C.E. CREDITS
SEP 14, 2021 7:00 AM PDT
Date: September 14, 2021 Time: 7am PDT, 10am EDT, 4pm CEST A conventional thermal cycler has long been a commodity product in the lab and end-point PCR techniques can be completed almost wit...
MAY 11, 2021 10:00 AM PDT
C.E. CREDITS
MAY 11, 2021 10:00 AM PDT
Date: May 11, 2021 Time: 10:00zm PDT Your samples are some of the most valuable assets in the laboratory. After spending countless hours on extraction and preparation, your conclusions could...
APR 01, 2021 8:00 AM PDT
C.E. CREDITS
APR 01, 2021 8:00 AM PDT
Date: April 01, 2021 Time: 8:00am (PST), 11:00am (EST) Generating therapeutic antibodies is far more challenging than obtaining antibodies that merely recognize their targets. Engineering po...
FEB 24, 2021 10:00 AM PST
C.E. CREDITS
FEB 24, 2021 10:00 AM PST
DATE: February 24, 2021 TIME: 10am PST Automated lab instruments such as liquid handlers and cell sorters are increasingly common in all types of laboratories, driving fast results for labor...
JUN 08, 2021 9:00 AM PDT
JUN 08, 2021 9:00 AM PDT
Date: June 8, 2021 Time: 9:00am PDT Reducing the spread of highly infectious and deadly diseases within the population, vaccine development is crucial in saving millions of lives each year....
MAR 18, 2021 8:00 AM PDT
C.E. CREDITS
MAR 18, 2021 8:00 AM PDT
DATE: March 18, 2021 TIME: 8:00am PDT Sequencing of bulk cells, single cells, and nuclei is opening doors in the understanding of complex biological processes....
OCT 01, 2015 6:00 AM PDT

Emerging role of liquid biopsies and NGS for biomarker discovery


No demographic data is available yet for this event.


Show Resources
Loading Comments...
Show Resources